How optimal is the medical management of patients prior to major reconstructive vascular surgery? The results of a cross-sectional study
- PMID: 19190039
- DOI: 10.1177/1538574408330399
How optimal is the medical management of patients prior to major reconstructive vascular surgery? The results of a cross-sectional study
Abstract
Background: Risk factor modification is important in patients with vascular disease. Guidelines suggest that this patient population benefits from a medical regimen of antiplatelets, statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors.
Materials and methods: The medical regimen of consecutive patients who presented for major vascular surgery intervention over 18 months was examined.
Results: Of the 325 patients identified, 176 (54%) were on antiplatelet treatment, 197 (61%) were on a statin, 180 (55%) on beta-blockers, and 146 (54%) on ACE inhibitors. A high-risk subset of 94 smokers with known coronary artery disease, hypertension, and hyperlipidemia or diabetes was identified. In this subset, patients were more likely to be on pharmacologic risk factor modification.
Conclusions: Despite recommendations, the pharmacologic risk factor modification of patients prior to vascular surgery remains suboptimal. Increased awareness of the problem and active participation of the vascular specialist are essential to improve compliance with established guidelines.
Similar articles
-
Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.Arch Gerontol Geriatr. 2009 Jan-Feb;48(1):116-20. doi: 10.1016/j.archger.2007.11.003. Epub 2008 Jan 4. Arch Gerontol Geriatr. 2009. PMID: 18177954
-
Re: Secondary medical prevention in patients with peripheral arterial disease.Eur J Vasc Endovasc Surg. 2008 Jan;35(1):59-60. doi: 10.1016/j.ejvs.2007.07.006. Epub 2007 Aug 27. Eur J Vasc Endovasc Surg. 2008. PMID: 17719805 No abstract available.
-
Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.Ann Vasc Surg. 2007 Mar;21(2):163-6. doi: 10.1016/j.avsg.2007.01.008. Ann Vasc Surg. 2007. PMID: 17349357
-
Peripheral arterial disease: a review of disease awareness and management.Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79. doi: 10.1016/j.amjopharm.2006.12.006. Am J Geriatr Pharmacother. 2006. PMID: 17296541 Review.
-
Optimal medical management of peripheral arterial disease.Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835. Vasc Endovascular Surg. 2006. PMID: 16959725 Review.
Cited by
-
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.Cochrane Database Syst Rev. 2013 Jul 3;2013(7):CD009971. doi: 10.1002/14651858.CD009971.pub2. Cochrane Database Syst Rev. 2013. PMID: 23824754 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
